0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HMO Formula Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-34R16201
Home | Market Reports | Shopping| Consumer Resources
Global HMO Formula Market Research Report 2024
BUY CHAPTERS

Global HMO Formula Market Research Report 2025

Code: QYRE-Auto-34R16201
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HMO Formula Market Size

The global market for HMO Formula was valued at US$ 3900 million in the year 2024 and is projected to reach a revised size of US$ 7856 million by 2031, growing at a CAGR of 11.0% during the forecast period.

HMO Formula Market

HMO Formula Market

HMO (Human Milk Oligosaccharides) formula milk refers to a specialized type of infant formula that incorporates oligosaccharides found naturally in human breast milk. These oligosaccharides are complex carbohydrates that serve various beneficial purposes, particularly for the infant’s digestive system and immune health. Breast milk is known to contain more than 200 different types of oligosaccharides, which play an important role in the development of the infant's gut microbiota, immunity, and overall health. Since these oligosaccharides are difficult to replicate, HMO formula has emerged as a substitute that mimics the benefits of breast milk, offering an advanced alternative for infants who may not have access to breastfeeding.
The primary purpose of HMO formula is to offer infants essential nutrients and bioactive components similar to those in breast milk. This includes providing support for immune defense, digestive health, and overall growth. The introduction of HMOs in infant formulas has revolutionized the infant nutrition market, offering a more scientific approach to supplementing breast milk for mothers who cannot breastfeed or who require additional support for their infants’ nutrition.
HMO formula milk typically comes in a range of variations to cater to specific infant needs. This includes:
Standard HMO formula: Aimed at healthy, full-term infants, providing all-around nutrition for growth and development.
Preterm and low birth weight HMO formula: Designed for premature or low birth weight infants, ensuring that their sensitive digestive systems receive the necessary support for optimal health.
Sensitive stomach HMO formula: Made for babies experiencing digestive discomforts like colic or reflux, this formula may contain additional components like probiotics or easier-to-digest proteins.
HMO formula with additional probiotics or nutrients: To support not just gut health but also immune development, these formulas combine HMOs with other beneficial ingredients such as probiotics, prebiotics, or DHA (docosahexaenoic acid).
The product is available in various forms such as powder, ready-to-feed liquid, and concentrated liquid, allowing parents to choose based on convenience and preference.
The market for HMO formula milk has experienced rapid growth due to several key factors. The growing awareness among parents of the critical role HMOs play in infant health has been a driving force. With increasing understanding of the benefits of HMOs in mimicking the bioactive components of breast milk, there is a rising demand for infant formulas that incorporate these oligosaccharides. As breastfeeding rates decline in some parts of the world, especially in urban areas, the demand for high-quality alternatives such as HMO formula milk has surged.
Market Opportunities: The emerging markets in Asia, Latin America, and the Middle East present significant growth opportunities for companies offering HMO-based formula milk. With rising disposable incomes and increased awareness of the importance of infant nutrition, these regions are expected to witness substantial demand for premium formula products. Innovations in production technologies, such as fermentation processes to create HMOs more efficiently, are also expected to make HMO-based formula more cost-effective, driving wider adoption across different demographics. Additionally, as more regulatory authorities approve the inclusion of HMOs in infant formula, companies have more opportunities to expand into new regions.
Market Risks: One of the major risks in the HMO formula market is the high production cost. The extraction and synthesis of HMOs remain an expensive and complex process, which can increase the price of the formula and limit its accessibility in price-sensitive markets. Regulatory challenges can also pose risks, as the approval of HMO inclusion in infant formula is still subject to different guidelines across regions. Furthermore, competition among major players in the market, including Abbott, Nestlé, Danone, and Mead Johnson, can limit market entry for smaller players, making it challenging for new companies to compete on price and innovation.
Market Concentration: The market is currently highly concentrated, with a few key players dominating the industry. Global giants like Abbott, Nestlé, Danone, and FrieslandCampina hold significant market share, primarily due to their established brand presence and distribution networks. This concentration of power limits opportunities for new entrants, although the growing consumer demand for HMO-based formula may attract smaller players looking to target niche segments of the market. However, as the market grows and diversifies, there may be room for more players to carve out a place.
Downstream Demand Trends: As consumer awareness about the benefits of HMO formula milk continues to rise, especially in developed markets, the demand for these formulas is expected to grow. Parents are increasingly looking for infant nutrition options that offer both convenience and nutritional superiority over traditional formulas. As breastfeeding rates are lower in some regions, particularly in developed countries, more parents are turning to HMO-based formulas to ensure their babies receive the best possible start in life. There is also a rising trend in seeking organic and clean-label formulas, which is likely to benefit the HMO formula segment as it is often marketed as a more natural and science-backed alternative to traditional formula milk.
Latest Technologies: The use of biotechnology in HMO production has been a major advancement in the field of infant nutrition. Companies are leveraging fermentation-based techniques to produce HMOs more efficiently and cost-effectively. These advances have the potential to reduce the cost of HMO formula milk, making it more accessible to a broader market. Additionally, the incorporation of other beneficial ingredients, such as prebiotics, probiotics, and DHA, alongside HMOs, is gaining traction as part of the latest innovations in the industry. These ingredients work synergistically to support the infant’s immune system, digestive health, and overall development.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HMO Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMO Formula.
The HMO Formula market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HMO Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HMO Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HMO Formula Market Report

Report Metric Details
Report Name HMO Formula Market
Accounted market size in year US$ 3900 million
Forecasted market size in 2031 US$ 7856 million
CAGR 11.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Powder
  • Liquid
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso), Yili Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HMO Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HMO Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is HMO Formula Market growing?

Ans: The HMO Formula Market witnessing a CAGR of 11.0% during the forecast period 2025-2031.

What is the HMO Formula Market size in 2031?

Ans: The HMO Formula Market size in 2031 will be US$ 7856 million.

Who are the main players in the HMO Formula Market report?

Ans: The main players in the HMO Formula Market are Abbott, Mead Johnson (Reckitt), Nestlé, Danone, FrieslandCampina(Friso), Yili Group

What are the Application segmentation covered in the HMO Formula Market report?

Ans: The Applications covered in the HMO Formula Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the HMO Formula Market report?

Ans: The Types covered in the HMO Formula Market report are Powder, Liquid

1 HMO Formula Market Overview
1.1 Product Definition
1.2 HMO Formula by Type
1.2.1 Global HMO Formula Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 HMO Formula by Application
1.3.1 Global HMO Formula Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global HMO Formula Market Size Estimates and Forecasts
1.4.1 Global HMO Formula Revenue 2020-2031
1.4.2 Global HMO Formula Sales 2020-2031
1.4.3 Global HMO Formula Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HMO Formula Market Competition by Manufacturers
2.1 Global HMO Formula Sales Market Share by Manufacturers (2020-2025)
2.2 Global HMO Formula Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HMO Formula Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HMO Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HMO Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HMO Formula, Product Type & Application
2.7 Global Key Manufacturers of HMO Formula, Date of Enter into This Industry
2.8 Global HMO Formula Market Competitive Situation and Trends
2.8.1 Global HMO Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HMO Formula Players Market Share by Revenue
2.8.3 Global HMO Formula Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HMO Formula Market Scenario by Region
3.1 Global HMO Formula Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HMO Formula Sales by Region: 2020-2031
3.2.1 Global HMO Formula Sales by Region: 2020-2025
3.2.2 Global HMO Formula Sales by Region: 2026-2031
3.3 Global HMO Formula Revenue by Region: 2020-2031
3.3.1 Global HMO Formula Revenue by Region: 2020-2025
3.3.2 Global HMO Formula Revenue by Region: 2026-2031
3.4 North America HMO Formula Market Facts & Figures by Country
3.4.1 North America HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HMO Formula Sales by Country (2020-2031)
3.4.3 North America HMO Formula Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMO Formula Market Facts & Figures by Country
3.5.1 Europe HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HMO Formula Sales by Country (2020-2031)
3.5.3 Europe HMO Formula Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMO Formula Market Facts & Figures by Region
3.6.1 Asia Pacific HMO Formula Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HMO Formula Sales by Region (2020-2031)
3.6.3 Asia Pacific HMO Formula Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMO Formula Market Facts & Figures by Country
3.7.1 Latin America HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HMO Formula Sales by Country (2020-2031)
3.7.3 Latin America HMO Formula Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HMO Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HMO Formula Sales by Country (2020-2031)
3.8.3 Middle East and Africa HMO Formula Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMO Formula Sales by Type (2020-2031)
4.1.1 Global HMO Formula Sales by Type (2020-2025)
4.1.2 Global HMO Formula Sales by Type (2026-2031)
4.1.3 Global HMO Formula Sales Market Share by Type (2020-2031)
4.2 Global HMO Formula Revenue by Type (2020-2031)
4.2.1 Global HMO Formula Revenue by Type (2020-2025)
4.2.2 Global HMO Formula Revenue by Type (2026-2031)
4.2.3 Global HMO Formula Revenue Market Share by Type (2020-2031)
4.3 Global HMO Formula Price by Type (2020-2031)
5 Segment by Application
5.1 Global HMO Formula Sales by Application (2020-2031)
5.1.1 Global HMO Formula Sales by Application (2020-2025)
5.1.2 Global HMO Formula Sales by Application (2026-2031)
5.1.3 Global HMO Formula Sales Market Share by Application (2020-2031)
5.2 Global HMO Formula Revenue by Application (2020-2031)
5.2.1 Global HMO Formula Revenue by Application (2020-2025)
5.2.2 Global HMO Formula Revenue by Application (2026-2031)
5.2.3 Global HMO Formula Revenue Market Share by Application (2020-2031)
5.3 Global HMO Formula Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott HMO Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Mead Johnson (Reckitt)
6.2.1 Mead Johnson (Reckitt) Company Information
6.2.2 Mead Johnson (Reckitt) Description and Business Overview
6.2.3 Mead Johnson (Reckitt) HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mead Johnson (Reckitt) HMO Formula Product Portfolio
6.2.5 Mead Johnson (Reckitt) Recent Developments/Updates
6.3 Nestlé
6.3.1 Nestlé Company Information
6.3.2 Nestlé Description and Business Overview
6.3.3 Nestlé HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nestlé HMO Formula Product Portfolio
6.3.5 Nestlé Recent Developments/Updates
6.4 Danone
6.4.1 Danone Company Information
6.4.2 Danone Description and Business Overview
6.4.3 Danone HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Danone HMO Formula Product Portfolio
6.4.5 Danone Recent Developments/Updates
6.5 FrieslandCampina(Friso)
6.5.1 FrieslandCampina(Friso) Company Information
6.5.2 FrieslandCampina(Friso) Description and Business Overview
6.5.3 FrieslandCampina(Friso) HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FrieslandCampina(Friso) HMO Formula Product Portfolio
6.5.5 FrieslandCampina(Friso) Recent Developments/Updates
6.6 Yili Group
6.6.1 Yili Group Company Information
6.6.2 Yili Group Description and Business Overview
6.6.3 Yili Group HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yili Group HMO Formula Product Portfolio
6.6.5 Yili Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMO Formula Industry Chain Analysis
7.2 HMO Formula Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMO Formula Production Mode & Process Analysis
7.4 HMO Formula Sales and Marketing
7.4.1 HMO Formula Sales Channels
7.4.2 HMO Formula Distributors
7.5 HMO Formula Customer Analysis
8 HMO Formula Market Dynamics
8.1 HMO Formula Industry Trends
8.2 HMO Formula Market Drivers
8.3 HMO Formula Market Challenges
8.4 HMO Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global HMO Formula Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global HMO Formula Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global HMO Formula Market Competitive Situation by Manufacturers in 2024
 Table 4. Global HMO Formula Sales (K Tons) of Key Manufacturers (2020-2025)
 Table 5. Global HMO Formula Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global HMO Formula Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global HMO Formula Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market HMO Formula Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of HMO Formula, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HMO Formula, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HMO Formula, Product Type & Application
 Table 12. Global Key Manufacturers of HMO Formula, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HMO Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Formula as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HMO Formula Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global HMO Formula Sales by Region (2020-2025) & (K Tons)
 Table 18. Global HMO Formula Sales Market Share by Region (2020-2025)
 Table 19. Global HMO Formula Sales by Region (2026-2031) & (K Tons)
 Table 20. Global HMO Formula Sales Market Share by Region (2026-2031)
 Table 21. Global HMO Formula Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global HMO Formula Revenue Market Share by Region (2020-2025)
 Table 23. Global HMO Formula Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global HMO Formula Revenue Market Share by Region (2026-2031)
 Table 25. North America HMO Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America HMO Formula Sales by Country (2020-2025) & (K Tons)
 Table 27. North America HMO Formula Sales by Country (2026-2031) & (K Tons)
 Table 28. North America HMO Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America HMO Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe HMO Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe HMO Formula Sales by Country (2020-2025) & (K Tons)
 Table 32. Europe HMO Formula Sales by Country (2026-2031) & (K Tons)
 Table 33. Europe HMO Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe HMO Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific HMO Formula Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific HMO Formula Sales by Region (2020-2025) & (K Tons)
 Table 37. Asia Pacific HMO Formula Sales by Region (2026-2031) & (K Tons)
 Table 38. Asia Pacific HMO Formula Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific HMO Formula Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America HMO Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America HMO Formula Sales by Country (2020-2025) & (K Tons)
 Table 42. Latin America HMO Formula Sales by Country (2026-2031) & (K Tons)
 Table 43. Latin America HMO Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America HMO Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa HMO Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa HMO Formula Sales by Country (2020-2025) & (K Tons)
 Table 47. Middle East and Africa HMO Formula Sales by Country (2026-2031) & (K Tons)
 Table 48. Middle East and Africa HMO Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa HMO Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global HMO Formula Sales (K Tons) by Type (2020-2025)
 Table 51. Global HMO Formula Sales (K Tons) by Type (2026-2031)
 Table 52. Global HMO Formula Sales Market Share by Type (2020-2025)
 Table 53. Global HMO Formula Sales Market Share by Type (2026-2031)
 Table 54. Global HMO Formula Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global HMO Formula Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global HMO Formula Revenue Market Share by Type (2020-2025)
 Table 57. Global HMO Formula Revenue Market Share by Type (2026-2031)
 Table 58. Global HMO Formula Price (US$/Ton) by Type (2020-2025)
 Table 59. Global HMO Formula Price (US$/Ton) by Type (2026-2031)
 Table 60. Global HMO Formula Sales (K Tons) by Application (2020-2025)
 Table 61. Global HMO Formula Sales (K Tons) by Application (2026-2031)
 Table 62. Global HMO Formula Sales Market Share by Application (2020-2025)
 Table 63. Global HMO Formula Sales Market Share by Application (2026-2031)
 Table 64. Global HMO Formula Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global HMO Formula Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global HMO Formula Revenue Market Share by Application (2020-2025)
 Table 67. Global HMO Formula Revenue Market Share by Application (2026-2031)
 Table 68. Global HMO Formula Price (US$/Ton) by Application (2020-2025)
 Table 69. Global HMO Formula Price (US$/Ton) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Abbott HMO Formula Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Mead Johnson (Reckitt) Company Information
 Table 76. Mead Johnson (Reckitt) Description and Business Overview
 Table 77. Mead Johnson (Reckitt) HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Mead Johnson (Reckitt) HMO Formula Product
 Table 79. Mead Johnson (Reckitt) Recent Developments/Updates
 Table 80. Nestlé Company Information
 Table 81. Nestlé Description and Business Overview
 Table 82. Nestlé HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Nestlé HMO Formula Product
 Table 84. Nestlé Recent Developments/Updates
 Table 85. Danone Company Information
 Table 86. Danone Description and Business Overview
 Table 87. Danone HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Danone HMO Formula Product
 Table 89. Danone Recent Developments/Updates
 Table 90. FrieslandCampina(Friso) Company Information
 Table 91. FrieslandCampina(Friso) Description and Business Overview
 Table 92. FrieslandCampina(Friso) HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. FrieslandCampina(Friso) HMO Formula Product
 Table 94. FrieslandCampina(Friso) Recent Developments/Updates
 Table 95. Yili Group Company Information
 Table 96. Yili Group Description and Business Overview
 Table 97. Yili Group HMO Formula Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Yili Group HMO Formula Product
 Table 99. Yili Group Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. HMO Formula Distributors List
 Table 103. HMO Formula Customers List
 Table 104. HMO Formula Market Trends
 Table 105. HMO Formula Market Drivers
 Table 106. HMO Formula Market Challenges
 Table 107. HMO Formula Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HMO Formula
 Figure 2. Global HMO Formula Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HMO Formula Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global HMO Formula Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global HMO Formula Market Share by Application: 2024 & 2031
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global HMO Formula Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global HMO Formula Market Size (2020-2031) & (US$ Million)
 Figure 12. Global HMO Formula Sales (2020-2031) & (K Tons)
 Figure 13. Global HMO Formula Average Price (US$/Ton) & (2020-2031)
 Figure 14. HMO Formula Report Years Considered
 Figure 15. HMO Formula Sales Share by Manufacturers in 2024
 Figure 16. Global HMO Formula Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest HMO Formula Players: Market Share by Revenue in HMO Formula in 2024
 Figure 18. HMO Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global HMO Formula Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America HMO Formula Sales Market Share by Country (2020-2031)
 Figure 21. North America HMO Formula Revenue Market Share by Country (2020-2031)
 Figure 22. United States HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe HMO Formula Sales Market Share by Country (2020-2031)
 Figure 25. Europe HMO Formula Revenue Market Share by Country (2020-2031)
 Figure 26. Germany HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific HMO Formula Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific HMO Formula Revenue Market Share by Region (2020-2031)
 Figure 33. China HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America HMO Formula Sales Market Share by Country (2020-2031)
 Figure 41. Latin America HMO Formula Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa HMO Formula Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa HMO Formula Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE HMO Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of HMO Formula by Type (2020-2031)
 Figure 52. Global Revenue Market Share of HMO Formula by Type (2020-2031)
 Figure 53. Global HMO Formula Price (US$/Ton) by Type (2020-2031)
 Figure 54. Global Sales Market Share of HMO Formula by Application (2020-2031)
 Figure 55. Global Revenue Market Share of HMO Formula by Application (2020-2031)
 Figure 56. Global HMO Formula Price (US$/Ton) by Application (2020-2031)
 Figure 57. HMO Formula Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Technical Support Outsourcing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26O5961
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Rolling Security Cart Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19483
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pet Carriers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2P7210
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Stem Sampler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y19788
Thu Sep 11 00:00:00 UTC 2025

Add to Cart